A small-cap biotechnology company focused on developing therapeutics and research platforms using 3D bioprinting technology to create functional human tissues. Its programs have centered on liver disease treatments and engineered tissue models used in drug discovery and toxicology testing. Investors...
No congressional trades have been disclosed for Organovo Holdings, Inc. (ONVO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.